Introduction
Glioblastoma (the World Health Organization [WHO] grade IV) is the most common primary brain tumor. The standard treatment of glioblastoma involves surgical excision followed by radiation treatment. Malignant gliomas have an extremely poor prognosis in spite of surgery, radiotherapy, and chemotherapy. Aggressive surgical resection of malignant gliomas in neurosurgery is an issue, which has been debated. But recently, it is observed that the survival time in such patients has modestly increased because of advances in surgical and intraoperative imaging techniques. 1 To improve prognosis, rapid growth and infiltration properties, hence complete resection is near impossible due to its tissue infiltration.
Craniotomy of a brain tumor with maximum EOR (%) is a good treatment to prolong a patient's survival time with an improved neurological status. 8 The goal of surgery is to establish a diagnosis of the lesion, reduction of mass effect, and to get a better response of adjuvant therapy such as radiation. Greater EOR gives a proportional improvement in medical outcome and reduction of morbidity. 9 Intraoperative techniques such as computed tomography (CT), ultrasound, 5-aminolevulinic acid fluorescence, and intraoperative magnetic resonance imaging (MRI) are in use to improve the percentage of EOR. 10 Recurrence is generally quick and there are limited studies regarding recurrent excisions and their effect on survival.
Being a very aggressive tumor, the cells of glioblastoma invade local tissues beyond the detectable reach of the radiographic imaging techniques. 10, 11 The microscopic invasion makes curative surgical resection almost impossible and recurrence is almost inevitable, even though postoperative imaging may suggest a complete resection of the tumor.
11,12
Patients with glioblastoma usually fall prey to relapses and recurrences; hence, the idea of repeated resections is often not embraced by many surgeons. A study, however, showed the significant prolongation of survival in patients who underwent resections more than four times for glioblastomas, but this was independent of the age of the patient or functional status. Repeated resections did not increase the morbidity of the patients. 13 Although, a poor evidence available about the relationship between resection extent and mean survival times 11, 13, 14 ; any surgery with 98% or greater resection and preservation of normal parenchyma along with neurological function was shown to have a greater improvement in the survival of the patients.
10
Patients and Methods
Patient Admission and Surgery
Total 270 histologically confirmed glioblastoma patients (►Fig. 1) were treated during the years 2004 to 2014 at the Neurosurgical Unit of Shaikh Zayed Hospital, Lahore, Pakistan. The demographic data on the patients were collected on a designated proforma. Brain tumor grades were identified according to the WHO classification system. Glioblastoma patients' tumors either had a burr-hole biopsy (freehand or with stereotaxy) or craniotomy and excision/ biopsy with and without stereotaxy. Tumors considered suitable for either gross total resection (GTR), subtotal resection (STR), partial resection (PR), or biopsy/decompression (BD) was decided on preoperative imaging by the neurosurgeons. Patients were screened through an outpatient clinic or emergency department of the hospital and admitted on the basis of neurosurgical indications or from workup of a diagnosis. After a careful history and examination, probable patients were admitted for imaging and other laboratory tests. Once the patients were admitted, a steroid therapy (dexamethasone 4 mg intravenously 6 hourly) and other medications were prescribed for symptomatic relief. Neuronavigation was used in most cases for the biopsy and excision of the lesions to help in aggressive resection, if so desired. A piecemeal excision of the tumor is generally preferred by the primary surgeon with an internal cavitation of the lesion being done first, and the excision being extended to the periphery of the lesion until normal tissue (►Fig. 2). Excision may be stopped before a complete macroscopic removal if deemed too near vital areas by the surgeon intraoperatively or in case of adverse events, such as excessive bleeding. Once the tumor margins are excised, the extent of excision again checked using image-guided surgery (IGS) probe. This prohibits the surgeon from damaging any surrounding normal brain tissue and this is the benefit of using IGS. A postoperative CT scan with contrast is done to see the EOR, bleeding, or any other abnormal development in the brain within 24 to 48 hours.
Statistical Analysis
A bivariate linear correlation was conducted to see the correlation between average survival time (AST) in months by the following predictors: patient age group (PAG), EOR % Role of Glioblastoma Craniotomy Related to Patient Survival Shahid, Hussain 133
and Karnofsky performance status (KPS) scale. 15, 16 The rvalues (Pearson coefficients) were obtained and analyzed to observe the strength and direction (AE) of the correlation. The p-values obtained were checked for the significance or nonsignificance of AST with the independent/predictor parameters, that is, PAG, EOR (%), and KPS score. A score of "0" was assigned to those patients who had KPS of equal to or greater than 80, whereas, a score of "1" was assigned to those patients who had KPS less than 80. The KPS scale and corresponding scores have been assigned to quantify patients' quality of life (QOL). Further, linear regression analyses were performed and R (square) (coefficient of determination) values were observed for the analysis of the preparation of variance in the dependent variable (AST), which can be subjected to be predicted from statistically significant independent variables: EOR (%) and KPS. The measure of the strength of AST's association was analyzed with statistically significant independent variables: EOR (%) and KPS. Further, R (square) values, model's coefficients, and p-values analyzed to estimate AST. Finally, regression equations were developed between independent variables (EOR and KPS) and the dependent variable (AST).
Results

Patients' Information and Histopathology
Total 270 glioblastoma patients were treated for the tumor resection during the years 2004 to 2014 with a follow-up of 2 years at the neurosurgical department of the Shaikh Zayed Hospital, Lahore, Pakistan. ►Fig. 1 shows WHO grade IV glioblastoma. This represents high endothelial proliferation with necrosis and cellular mitosis. 17 The pattern shows high endothelial proliferation with a showing of necrosis and cellular mitosis. 17 ►Fig. 2 shows the craniotomy for glioblastoma excision of the frontal lobe. There were 50 patients whose tumor was less than 2 cm, 150 patients' tumor was 2 to 4 cm, and there were 70 patients whose tumor was greater than 4 cm. ►Fig. 
Number of Resections, Radiotherapy, and Chemotherapy Status
The 2% of the glioblastoma patients' tumors were resected three times and 15% of tumors were resected twice. The 95% patients had fractioned radiation with a dose of 60 Gy. Total 130 patients had a craniotomy and excision/biopsy of gliomas without stereotaxy, while 92 patients had a stereotactic craniotomy with excision or biopsy. The 42 patients had a free hand burr-hole biopsy and 6 patients had a frontal or temporal lobectomy. Patients were followed up for 2 years at 6-month intervals with clinical evaluation (KPS scale). Only 20% of these patients also received adjuvant therapy with temozolomide which is a standard effective chemotherapy and the average survival increased from 4 to 7 months in glioblastoma patients.
Statistical Inferences
►Table 1 shows the number of patients resected for a respective surgery procedure. ►Table 2 shows the glioblastoma PAG, EORs, that is, GTR, STR, PR, and BD and respective patients' AST. The neurosurgical record shows that 10% of glioblastoma patients were from the age group 18 to 35 years, 20% were from the age group 36 to 53 years, and 70% were from the age group 54 to 71 years. The least survival time (7 months) has been noticed in the PAG 18 to 35 years by BD resection, whereas, the maximum survival time (14.5 months) has been noticed by the PAG 54 to 71 years by GTR. Maximum number (n ¼ 76) of patients had been resected with PR, having AST of 10.5 months. A second maximum number (n ¼ 56) of patients has been treated with BD and they were having the AST of 8 months. Total 190 patients 
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out of 270, with EOR (100-80%) had a KPS score "0" (80 and above) and total 80 patients out of 270 patients, with EOR (50%) had had a KPS score "1" (below 80). ►Table 3 shows a correlation analysis between patients' AST in months with the EOR (50-100%), PAG in years, and KPS score. Correlation analysis was performed for the AST to see the strength of association with patients' age groups, EOR done and KPS score. The correlation is statistically significant at (p < 0.050) for EOR (%) and KPS score (0/1). The correlation is nonsignificant for a PAG (p > 0.050). It is observed that EOR (50-100%) has a positive strong relationship with the patients' AST (months); whereas, KPS has a strong negative relationship with the patients' AST (months). It means that maximum resection has a strong impact on the glioblastoma patient's survival; whereas a lesser EOR (%) correlated with poor QOL, leading a decreased survival of patients.
Two regression models were developed to estimate the effect of an independent variable AST (months) on respective two independent parameters, that is, EOR (%) and KPS score, which were found statistically significant in the correlation analysis. ►Table 4 shows two regression models for the statistically significant predictors (EOR and KPS score) and related statistics. For every unit increase in EOR (%) there is a 0.113 unit increase in an AST of a patient and for every unit decrease in KPS score, there is a 3.811 increase in AST for a patient. The regression equations are as follows:
; where x 1 is EOR (%) and x 2 is KPS
Discussion
Glioblastoma is the most common and aggressive primary brain tumor, which is prone to recur. [13] [14] [15] Malignant glioblastoma (WHO grade IV) represents one of the most calamitous diseases. It appears to be a common sense that increasing resection would benefit patient survival. While this is established that for a total or near-total resection of less than 80% has not been correlated with a progressively decreasing survival. This study has analyzed the role of maximum surgical resection of malignant gliomas. Studies have found that a tumor resection of 98% or more is an independent variable correlated with longer survival in glioblastoma patients. 16, 17 There is a debate in the neurosurgery related to the efficacy of maximum resection of malignant gliomas, because malignant gliomas are invasive to the surrounding tissues of the brain, therefore, sometimes wide resections are not possible because of the close vicinity of eloquent areas of the brain. Some prospective studies are also available that have reported a favorable relationship between the EOR of gliomas and survival time. 18 It was identified that a maximum resection has a strong association with the glioblastoma patient's survival. Studies 19, 20 have shown that patients, whose brain tumors had previously been resected completely, acquired greater benefit from temozolomide as part of the adjuvant treatment, compared with those patients whose Abbreviations: BD, biopsy/decompression; EOR, extent of resection; GTR, gross total resection; mo, months; PAG, patients' age group; PR, partial resection; STR, subtotal resection. a Number of patients.
Note: The average survival time is mentioned within the parenthesis. Craniotomy and frontal/temporal lobectomy tumor resection was less. In the current study, only 20% of patients were treated with temozolomide due to cost and affordability reasons. If all glioblastoma patients had been receiving temozolomide therapy then survival time would have been increased 3 to 7 months on average. For a multiplicity of reasons, only 20% of glioblastoma patients achieved a complete resection of the tumor.
20,21
A retrospective study was conducted on anaplastic astrocytomas and glioblastoma patients' with following parameters: location of the tumor, EOR, performance status, and radiotherapy treatments. 22 This study believed neurological improvements through radiotherapy and the researchers concluded that young age and a good performance (postoperative) status were linked with longer survival in anaplastic astrocytomas but not in glioblastomas. 22 In both, anaplastic astrocytomas and glioblastoma patients, an extensive surgery was associated with improved postoperative conditions.
22
Another previous study was conducted on glioblastoma patients and analyzed patient survival time with respect to some already known prognostic factors, including KPS, age, EOR, and site & size of the tumor. 23 The patients who underwent total resection had an average survival of 11.3 months as compared with those patients, who were treated only with a biopsy. 23 There is also a debate in literature as to whether overall patient survival can be prolonged if GTR is performed at the recurrence, regardless of the previous EOR, as some authors coming out in favor of reoperation. 2 Another study has also shown that patients with recurrent glioblastoma can have an improved life expectancy by repeated surgical resections. 13, 14 It was reported that the sole potential adjustable risk factor is associated with a survival time of glioblastoma patient is EOR of the tumor. While there are other studies which demonstrated an association between GTR and a prolonged survival for glioblastoma. However, it is also known that GTR is not always possible. A maximal EOR and minimal residual volume were independently correlated with a prolonged survival time and a slowed tumor recurrence. 13, 14 Several studies have favored a maximum EOR which is associated with longer survival. 10 A retrospective study of glioblastoma patients identified patients' age < 60 years and KPS score ! 70 as significant positive prognostic factors. 24 Older patients with glioblastoma are considered to have poor prognoses and are therefore rarely treated with aggressive resection. Some neuro-oncologists favor aggressive surgery, which may protract survival time for older glioblastoma patients. Other studies report older patients with aggressive resection and tumor size larger than 4 cm may not be getting much benefit from aggressive surgery.
13,14
It was reported that survival has significantly been improved to an EOR greater than 98%. 10 A study had identified that those patients whose tumors were resected experienced a median survival of 5.7 months, whereas, those patients who were treated with a needle biopsy, experienced 4 months of median survival time.
25 Table 4 Regression analyses between two statistically significant (p < 0.050) predictors: EOR, KPS (score), and AST 
